Google
Trusted Resources: Evidence & Education
Scientific literature and patient education texts
Hematopoietic Stem Cell Transplantation in Children With Sickle Cell Anemia: The Parents’ Experience
source: Pediatric Transplantation
year: 2019
authors: Cavadini R, Drain E, Bernaudin F, D'Autume C, Giannica D, Giraud F, Baubet T, Taïeb O
summary/abstract:Genoidentical HSCT is currently the only curative treatment for SCA, preventing further vascular complications in high-risk children. Studies on the psychological implications of HSCT for recipient, sibling donor, and the rest of the family have been limited in SCA. This study enrolled ten families and used semi-structured interviews to explore the parents’ experience at three time points: first before transplantation, then 3 months later, and 1 year later. Three themes emerged from the results: (a) the presence of anxiety, experienced throughout the process, and alleviated by coping strategies (positive thinking, family support, praying); (b) the ability to remain parents to recipient and other family members, despite apprehension and feelings of helplessness, reinforced by the mobilization of important resources at the individual/family levels; (c) the ability to acknowledge the opportunity for their child to be cured of the disease, despite feelings of guilt toward families without a donor, or their own families back home. Overall, the parental experience with HSCT is complex, involving intra-psychic, familial, cultural, religious, and existential factors. Thus, it is important for medical teams to be cognizant of these issues in order to provide the best support to families during the HSCT process.
organization: Hôpital Maison Blanche, France; Paris XIII University & Assistance Publique-Hôpitaux de Paris, France; Centre Hospitalier Intercommunal, FranceDOI: 10.1111/petr.13376
read more
+myBinderRelated Content
-
Barbara Yawn, MDBarbara P. Yawn, MD, MSc, FAAFP, is Adju...
-
Sickle Cell & Me: Survivor Discussion with Clarisse H. (Sickle Cell Survivor)The Lambda Epsilon Sigma Chapter of Sigm...
-
Hydroxyurea Therapy Prevents High Risk Trans-Cranial Doppler Development in Children with Sickle Cell DisordersAnnual evaluation by Trans-Cranial Doppl...
-
Acute Care Utilization in Pediatric Sickle Cell Disease and Sickle Cell Trait in the USA: Prevalence, Temporal Trend...The objective of this study was to analy...
-
Crux of the matter with Elsie: Sexual Disposition of Sickle Cell WarriorsWhether we like it or not, sex is import...
-
Sickle Cell Disease Association of America, Inc., the Sickle Cell Foundation of Georgia, Inc., and the American Red ...The Sickle Cell Disease Associ...
-
Yutaka Niihara, MD, MPHDr. Niihara has been involved in patient...
To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences. More Information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Powered by
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.